Alembic Pharma gets USFDA nod for insomnia treatment drug

New Delhi: Drug firm Alembic Pharmaceuticals has received approval from the US health regulator for Temazepam capsules, used for treatment of insomnia.

The company has got approval from the US Food and Drug Administration (USFDA) to market the drug in the strength of 7.5mg, 15mg, 22.5mg and 40mg, Alembic Pharmaceuticals said in a BSE filing.

The approved abbreviated new drug application (ANDA) is the therapeutic equivalent to the reference listed drug product (RLD) Restoril Capsules.

Quoting IQVIA sales data, the company said, Temazepam capsules 7.5mg, 15mg, 22.5mg and 40mg had an estimated market size of USD 48 million for 12 months, ending December 2017.

The company’s stock was trading at Rs 567 apiece, up 1.33 per cent, on the BSE.

  • Related Posts

    Unauthorised Pakistani cosmetics worth ₹7 lakh seized from Hyderabad’s Nampally and Habeeb Nagar stores

    The CDSCO notice flagged that certain such products contained heavy metals beyond permissible limits, potentially posing health risks to consumers, said the Police Cosmetic products manufactured in Pakistan and allegedly…

    FSSAI suspends licence of Delhi-based hospitality establishment for ‘serious non-compliance’

    New Delhi: The Food Safety and Standards Authority of India (FSSAI) has suspended the food business licence of Delhi’s Seven Seas Hospitality, based in Rohini, over non-compliance with norms and…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Unauthorised Pakistani cosmetics worth ₹7 lakh seized from Hyderabad’s Nampally and Habeeb Nagar stores

    Unauthorised Pakistani cosmetics worth ₹7 lakh seized from Hyderabad’s Nampally and Habeeb Nagar stores

    FSSAI suspends licence of Delhi-based hospitality establishment for ‘serious non-compliance’

    FSSAI suspends licence of Delhi-based hospitality establishment for ‘serious non-compliance’

    Meet Samrat of Robotic Surgery, poised to bring Dawn of Cutting-edge Healthcare in Bihar

    Meet Samrat of Robotic Surgery, poised to bring Dawn of Cutting-edge Healthcare in Bihar

    Pushpanjali Medicon: ‘No Lunch Break’ Marathon of Medical Matters

    Pushpanjali Medicon: ‘No Lunch Break’ Marathon of Medical Matters

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

    Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks